DE GUZMAN SAN DIEGO MEJIA & HERNANDEZ
  • Home
  • ABOUT US
  • Our Practice
  • OUR LAWYERS
  • CONTACT US
  • News and Updates
    • SUMMARY GOVERNMENT ISSUANCES RELATING TO COVID-19
DEPARTMENT OF TRANSPORTATION
  • Advisories & Guidelines
  • Press Releases
<
>
Issuance No.
Date of Issuance
Subject Matter
Advisory from the Office of the Transportation Cooperatives
​26 March 2020
​Government Assistance for the Transport Cooperatives


​Guidelines
​Undated
Guidelines for the Management of Emerging Infectious Disease
Issuance No.
Date of Issuance
Subject Matter
Press Release
​18 March 2020
​DOTr Extends Deadline For Renewal Of Permits, Licenses, Franchises To April 2020
Press Release
20 March 2020
DOTr Rolls Out 74 Units, Increases New Routes To 13 For The Free Ride Program For Health Workers Affected By Enhanced Community Quarantine
​Press Release
​24 March 2020
3 DOTr agencies remit over Php 10 billions dividends in advance to fund PHL’s fight vs. COVID-19, other gov’t projects
​Press Release
​24 March 2020
​DOTr Emergency Operations Center Opens Hotline for Transportation Concerns Amid COVID 19 Quarantine
​Press Release
​25 March 2020
DOTr Readies Contingency Actions for PH Aviation Sector AMID COVID-19 uarantine; Implementation of “Rental Holidays” and Deferred Payment of Rental Chargers for Airport Concessionaires…
​Press Release
​27 March 2020
3 DOTr Agencies Remit Over Php 10 billion dividends in advance to fund PHL’s fight vs. COVID-19, other Gov’t Projects
​Press Release
5 April 2020
Tuloy-tuloy na Serbisyo, hatid ng DOTr sa Kabila ng Nararanasang COVID-19 Pandemic
​DOTr-PPA Press Release
​7 April 2020
DOTr, PPA renew calls to shippers, consignees to withdraw overstaying cargoes as Manila ports reach over 90% yard utilization
​Press Release
​2 May 2020
Tugade Orders CAAP, Airport Authorities To Seriously Consider Opening Of Airports In GCQ, Areas For Commercial Operations
​DOTr Press Statement
3 May 2020
On the decision of the National Task Force Against COVID-19 for the TEMPORARY SUSPENSION OF USAGE of all PH international airports for inbound international passenger flights
ENERGY REGULATORY COMMISSION
Issuance No.
Date of Issuance
Subject Matter
Advisory for DUs
​11 March 2020
​New Deadline For The Filing Of Applications For The Approval Of Over/Under Recoveries
​Advisory (2/2)
​13 March 2020
Skeletal Workforce; Cancellation Of Scheduled Hearings, Conferences, Pre-Filing Conferences
​Advisory
​17 March 2020
Work from Home Policy
​Advisory
​26 March 2020
Extension of Payment
​Advisory
​15 April 2020
Directives to guide the electric power industry stakeholders
​Advisory
5 May 2020
In Line With The Government’s Directive Extending Anew the Enhanced Community Quarantine (ECQ) in the National Capital Region (NCR) And Some Other Areas Until 15 May 2020, The ERC Hereby Amends And Clarifies Some Items In The 15 April 2020 Advisory For The Proper Guidance Of Electric Power Industry Stakeholders On The Further Extension Of The Grace Period Of Payment In Of Their Consumers’ Electricity Bills Falling Due Within The ECQ period of 16 March to 15 May 2020, without interest, penalties, fees and other charges, grace period to be given for the payment of DUs’ and RES’ consumers’ electricity bills
FOOD AND DRUGS ADMINISTRATION
  • Advisories
  • Announcement
  • ​Circulars
  • Memorandum Circulars
  • Press Releases
<
>
Issuance No.
Date of Issuance
Subject Matter
FDA Advisory No. 2020-350
​16 March 2020
​List of Notified Hand Sanitizers
​FDA Advisory No. 2020-409
​19 March 2020
​List of Approved COVID-19 Test Kits for Commercial Use
​FDA Advisory No. 2020-420
​​20 March 2020
​Procedure for FDA Clearance of Personal Protective Equipment (PPE) Prior Customs Release
​FDA Advisory No. 2020-421
​​​20 March 2020
​Hand Sanitizer, Antibacterials and Antiseptic Sold Through Online Stores
​​​​FDA Advisory No. 2020-422
​​​20 March 2020
​​Updated List of Notified Hand Sanitizers and Registered Topical Anti-septics and Anti-bacterials
​​FDA Advisory
​​22 March 2020
​​Wala Pang Aprubadong Point-of-Care o Instant COVID 19 Test Kits
FDA Advisory No. 2020-449
​23 March 2020
​FDA Clearance of Ventilators, Respirators, and Accessories Prior Customs Release​
​​FDA Advisory No. 2020-178-A​
​​27 March 2020
​​Lifting the Advisory of the Registered Medical Device under FDA Advisory No. 2020-178, subject “Public Health Warning Against the Purchase and Use of the Unregistered Medical Device Alaris Secondary Syringe Adapter”
​​FDA Advisory No. 2020-450
​27 March 2020
​​Pharmacies to Dispense Hydroxychloroquine to Patients with Prescriptions for the Drug Use
​​FDA Advisory No. 2020-451
​27 March 2020
​FDA E-mail Hotline for COVID-19 Related on Consumer Products
​FDA Advisory No. 2020-452
​30 March 2020
​Baseless Claims of “Prodex-B” as Anti-Viral Treatment for COVID-19
FDA Advisory No. 2020-496
​30 March 2020
​Public Health Warning Against Do-It-Yourself Hand Sanitizers/Disinfectants
​FDA Advisory No. 2020-483
30 March 2020
​List of Approved COVID-19 Rapid Antibody Test Kits
​FDA Advisory No. 2020-498
​1 April 2020
Purchase and Administration of FDA Approved COVID-19 Rapid Antibody Test Kits
​FDA Advisory No. 2020-497
​1 April 2020
​Distribution of  FDA Approved COVID-19 Rapid Antibody Test Kits
​FDA Advisory No. 2020-744
23 April 2020
Advisory for the Issuance of Special Permit for Medical Radiation Facilities Using Loaned Mobile X-Ray Devices During the COVID-19 Pandemic
Issuance No.
Date of Issuance
Subject Matter
Announcement
​23 April 2020
​FDA Announcement on the Approval of 10 Additional Kits (4 PCR, 6 RAPID) as of 22 April 2020
​Announcement
24 April 2020
Announcement of FDAC Additional Hotlines
 
 
 
Announcement
29 April 2020
FDA approved 2 additional kits (1 PCR, 1 RAPID) as of 29 April 2020. Total registered COVID-19 Test Kits for commercial use is now 59.
​Announcement
​29 April 2020
Updated List of Notified Hand Sanitizers and Rubbing Alcohol Products as of 29 April 2020
​Announcement
4 May 2020
​FDA approved 11 additional kits (3 PCR, 8 RAPID) as of 04 May 2020. Total registered COVID-19 Test Kits for commercial use is now 70.
Announcement
5 May 2020
FDA approved 5 additional kits (1 PCR, 4 RAPID) as of 05 May 2020. Total registered COVID-19 Test Kits for commercial use is now 75.
Issuance No.
Date of Issuance
Subject Matter
FDA Circular No. 2020-004
12 March 2020
​Prohibition of Selling of COVID-19 Testing kit without Authorization from FDA
​FDA Circular No. 2020-005
12 March 2020
Prohibition on the Online Selling of Essential Medical Supplies Beyond the Price Ceiling/Range set by Department Memorandum No. 2020-0058 and Department Memorandum No. 2020-0058-A
​FDA Circular No. 2020-006
17 March 2020
Guidelines for Applications and Transactions at the Food and Drug Administration in Light of the Community quarantine Declaration
FDA Circular No. 2020-007
17 March 2020
Guidelines in the Implementation of the Use of Electronic Means of Prescription for Drugs for the Benefit of Individuals Vulnerable to COVID-19
FDA Circular No. 2020-009
19 March 2020
Guidelines on the Identification, Notification, Evaluation, Regulatory Enforcement Action, and Review and Monitoring of Donated Health Products Solely Intended to Address COVID-19 Public Health Emergency
FDA Circular No. 2020-005-A
​20 March 2020
​Amendment to FDA Circular No. 2020-005 Re: Prohibition on the Online Selling of Essential Emergency Medical Supplies Beyond the Price Ceiling/Range Set by the Department Memorandum No. 2020-0058 and Department Memorandum No. 2020-0058-A
​FDA Circular No. 2020-013
​3 April 2020
Guidelines for Monitoring Drug Products Used for the Treatment of COVID-19
​FDA Circular No. 2020-012
3 April 2020
Guidelines for the Registration of Drug Products under Emergency Use (DEU) for the Coronavirus Disease 2019 (COVID-19)
​FDA Circular No. 2020-006-A
​3 April 2020
Amendment to FDA Circular No. 2020-006 Entitled “Guidance for Applications and Transactions at The Food and Drugs Administration in Light of the Community Quarantine Declaration” Issued on 17 March 2020
​FDA Circular No. 2020-013
3 April 2020
​Guidelines for Monitoring Drug Products Used for the Treatment of COVID-19
​FDA Circular No. 2020-015
​21 April 2020
Interim Measures to Ensure Access to Vitamin Drug Products During the Coronavirus Disease 2019 (COVID-19) Pandemic
​FDA Circular No. 2020-009-B
29 April 2020
Amendment to Include Respiratory Therapy Devices in the List of Medical Devices Covered by FDA Circular No. 2020-009, as Amended by FDA Circular No. 20209-009-A
Issuance No. 
Date of Issuance
Subject Matter
FDA Memorandum No. 2020-011
​20 April 2020
​Performance Testing of Antibody Test Kits with Issued Special Certifications
​Memorandum Circular No. 2020- ___
​16 March 2020
​Closing of Immunization Section
​Memorandum Circular No. 2020-001
​19 March 2020
Interim Guidelines for the Issuance of Provisional License to Operate (LTO) and Certificate of Product Notification (CPN) for Manufacturers of Rubbing Alcohol Products Under the Center for Cosmetics Regulation and Research
Memorandum Circular No. 2020-06
​28 February  2020
North Gyeongsang Province, South Korea Travel Restrictions
​Memorandum Circular No. 2020-07
3 March 2020
Guidelines at all Seaports for Prevention and Spread of Novel Coronavirus COVID-1
Memorandum Circular No. 2020-001-A
16 April 2020
Amendment to FDA Memorandum Circular No. 2020-001 entitled Interim Guidelines for the Issuance of Provisional License to Operate (LTO) and Certificate of Product Notification (CPN) for Manufacturers of Rubbing Alcohol Products Under Cosmetics Regulation and Research
Issuance No.
Date of Issuance
Subject Matter
Press Release
​9 March 2020
​FDA Allows Use of COVID 19 Test Kits Developed by Local Scientists
Press Release ​
​9 March 2020
FDA Allows Use of COVID 19 Test Kits Developed by Local Scientists
​Press Release
15 March 2020
FDA Clarifies Availability of COVID-19 Test Kits in the Country
Press Release
21 April 2020
FDA Press Statement: RITM to Evaluate FDA Approved COVID-19 Rapid Antibody Test Kits
GOVERNMENT PROCUREMENT POLICY BOARD
Issuance No.
Date of Issuance
Subject Matter
GPPB Circular No. 01-2020
6 April 2020
​Guidelines on the Emergency Procurement under the Bayanihan Act
​GPPB Resolution No. 03-2020
9 March 2020
​Guidelines on Negotiated Procurement under Emergency Cases Amidst COVID-19 Pandemic     
​GPPB Resolution No. 04-2020
19 March 2020
Approving The Extension Of Deadline For The Submission Of 2019 Agency Procurement Compliance And Performance Indicator (APCPI) Results Of The Procuring Entities
​GPPB Resolution No. 05-2020
​20 March 2020
Approving The Acceptance Of An Expired Mayor’s Permit With Official Receipt For The Renewal Application And Unnotarized Omnibus Sworn Statement As Basis For Award Under The Negotiated Procurement (Emergency Cases) Modality   ​
​GPPB Resolution No. 06-2020
6 April 2020
Approving the Circular setting the Guidelines on the Emergency Procurement under Republic Act No. 11469 or the Bayanihan Act and recommending for approval of the President the increase of advance payment to 30% for Procurement Projects covered under the Bayanihan Act
Back

Email

General Queries:
counsel@gsmhlaw.com
Partners:
partners@gsmhlaw.com
Accounting:
accounting@gsmhlaw.com

Telephone

(+632) 8511.0908
(+632) 8511.0925

Fax

(+632) 8877.6006

DE GUZMAN SAN DIEGO
​
MEJIA & HERNANDEZ

16th Floor, Trident Tower Building
312 Sen. Gil Puyat Ave., Salcedo Village
Makati City, Philippines, 1200

Picture
© COPYRIGHT 2020. ALL RIGHTS RESERVED.
  • Home
  • ABOUT US
  • Our Practice
  • OUR LAWYERS
  • CONTACT US
  • News and Updates
    • SUMMARY GOVERNMENT ISSUANCES RELATING TO COVID-19